Werewolf Therapeutics Inc
For the period ended Dec 31, 2023. Filed Mar 7, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 7, 2024
HOWL$0.97-4.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibit and Financial Statement Schedules
| (1) Financial Statements | |
|---|---|
| Report of the Independent Registered Public Accounting Firm (PCAOB ID No. 42) | 104 |
| Consolidated Balance Sheets | 105 |
| Consolidated Statements of Operations | 106 |
| Consolidated Statements of Stockholders’ Equity | 107 |
| Consolidated Statements of Cash Flows | 108 |
| Notes to Consolidated Financial Statements | 109 |
| (2) Financial Statement Schedules | |
| Schedules have been omitted since they are either not required or not applicable or the information is otherwise included herein. | |
| (3) Exhibits | |
| The exhibits filed or furnished as part of this Annual Report are listed in the Exhibit Index immediately preceding the signatures, which Exhibit Index is incorporated herein by reference. | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.